A systematic review and network meta-analysis of eight randomized controlled trials involving 1,803 biliary tract cancer patients found that adjuvant chemotherapy significantly enhances relapse-free survival and overall survival compared to observation alone. Notably, gemcitabine-based chemotherapy outperformed fluorouracil-based treatments in reducing recurrence rates. The analysis indicates that postoperative chemotherapy should be a standard recommendation following curative resection, particularly for patients with negative margins and lymph node involvement, to optimize survival rates.
Journal Article by Peng Y, Liang A (…) Cheng Y et 6 al. in Int J Surg
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.